Home > Insider Trading > Filing (0001209191-18-020553)

Filing Details

Accession Number:: 0001209191-18-020553
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-19 16:06:40
Reporting Period:: 2018-03-15

Accepted Time:: 2018-03-19 16:06:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293971	Bluebird Bio Inc.	BLUE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614018	Mark Vachon	C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-15	6,000	$30.47	7,000	No	4	M	Direct
Common Stock	Disposition	2018-03-15	1,000	$211.11	6,000	No	4	S	Direct
Common Stock	Disposition	2018-03-15	950	$212.72	5,050	No	4	S	Direct
Common Stock	Disposition	2018-03-15	550	$213.61	4,500	No	4	S	Direct
Common Stock	Disposition	2018-03-15	1,600	$214.76	2,900	No	4	S	Direct
Common Stock	Disposition	2018-03-15	1,200	$215.84	1,700	No	4	S	Direct
Common Stock	Disposition	2018-03-15	400	$217.24	1,300	No	4	S	Direct
Common Stock	Disposition	2018-03-15	300	$220.20	1,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2018-03-15	6,000	$0.00	6,000	$30.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,000		2024-07-16	No	4	M	Direct

Footnotes

The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2017.
The range in prices for the transaction reported on this line was $210.75 to $211.60. The average weighted price was $211.1083. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $212.10 to $213.05. The average weighted price was $212.7231. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range of prices for the transaction reported on this line was $213.10 to $214.05. The average weighted price was $213.6132. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range of prices for the transaction reported on this line was $214.35 to $215.05. The average weighted price was $214.7563. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range of prices for the transaction reported on this line was $215.50 to $216.40. The average weighted price was $215.8355. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range of prices for the transaction reported on this line was $217.00 to $217.80. The average weighted price was $217.2375. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This option vests ratably over three years in annual installments, commencing on July 16, 2015.